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Aims: To evaluate the effectiveness of a new test, the Pupilmetrix™ PLR60, which uses the 
pupillary light reﬂ  ex (PLR) to detect asymmetric retinal damage in patients diagnosed with 
glaucoma.
Methods: 30 patients, clinically diagnosed as having glaucoma, were recruited to the study, 
29 of whom completed testing using the PLR60. A control group of 30 patients who had 
glaucoma excluded by clinical examination were also recruited and tested using the same 
protocol on the PLR60.
Results: Of the 110 eyes with test outcomes, overall agreement between the PLR60 result and 
clinical diagnosis (glaucoma positive or negative) per eye was 84.7%. Sensitivity was 93.1% 
(95% CI 77.2%–99.2%) and speciﬁ  city was 76.7% (95% CI 57.7%–90.1%). Average (SD) test 
times (min:sec) for both eyes were 3:21 (0:33) minutes for the glaucoma group and 2:40 (0:35) 
minutes for the non-glaucoma group.
Conclusions: The results of this preliminary study suggest that the PLR as used in the 
Pupilmetrix™ PLR60 test is able to discriminate between patients with glaucomatous retinal 
defects and those with clinically normal retinas with a diagnostic accuracy that is potentially 
useful for screening for glaucoma. Test times were markedly quicker than with standard visual 
ﬁ  eld testing.
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Introduction
Glaucoma is a progressive optic neuropathy which, if untreated, can lead to severe 
damage to the visual ﬁ  eld. The major risk factor for the disease is intraocular pressure 
(IOP) which, through an ill-understood mechanism, damages the ganglion cell layer of 
the retina. This manifests itself as progressive damage to the visual ﬁ  eld. The disease is 
diagnosed by clinical examination of the optic nerve head and the visual ﬁ  eld, although 
because of the high variability involved in visual ﬁ  eld testing it can be difﬁ  cult to 
identify people with early disease. For this reason there has been a continuing search 
for a method of objectively examining the retina for signs of glaucomatous damage. 
The early results of one such method are presented in this paper.
As glaucoma progresses, damage to the retinal nerve ﬁ  bres is often asymmetric 
between the upper and lower retina.1,2,3 Using these principles, Asman and Heijl4 
reported the development of the ‘Glaucoma Hemiﬁ  eld Test’ which used standard 
perimetric results obtained from the Humphrey ﬁ  eld analyser to empirically determine 
so called ‘up-down’ differences in the probability maps to detect localized visual 
ﬁ  eld loss. The method is based on the knowledge that early visual ﬁ  eld defects (in 
glaucoma) are frequently restricted to either the upper or lower hemiﬁ  eld and that 
localized defects are manifested by asymmetries in the differential light sensitivities 
across the horizontal meridian.
Chen5 proposed that this asymmetric change, characteristic of glaucomatous retinal 
nerve ﬁ  bre damage, may be detectable as asymmetries in relative sensitivity of the Clinical Ophthalmology 2009:3 124
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pupillary light reﬂ  ex (PLR) in the upper and lower retinal 
hemiﬁ  eld. In the paper, Chen also reported the development 
of a rapid, objective, quantitative measure of asymmetry of 
this retinal sensitivity, using infrared pupillometry and pairs 
of large, functionally designed stimuli, symmetrical about 
the horizontal meridian of the retina.
This approach to determination of retinal asymmetric 
function within an eye was proposed to be applicable to 
testing patients with glaucoma. In 2008, Chen6 further 
reported that pupillary evaluation of retinal asymmetry in a 
test group of 40 glaucoma patients and 40 control patients 
agreed with perimetry in 70% of eyes tested.
This current paper reports the ﬁ  rst clinical results obtained 
from a medical device (the Pupilmetrix™ PLR60; Applied 
Neurodiagnostics Ltd, Cramlington, UK) designed to employ 
the test developed by Chen et al5,6 to rapidly identify patients 
with and without glaucoma.
Materials and methods
The study was wholly conducted at Sunderland Eye 
Inﬁ  rmary, Sunderland, UK and was approved by the UK 
NHS National Research Ethics Service (NRES) and the 
local R and D committee. Participants were patients attend-
ing the hospital and two groups were identiﬁ  ed – one with 
clinical diagnosis of glaucoma and a second who clinically 
did not have glaucoma or personal history or family history 
of the disease. Both sets of patients were examined by the 
same person (an ophthalmologist with a special interest in 
glaucoma) and all underwent the same tests for glaucoma 
(ie, IOP measurement, disc examination, visual ﬁ  eld test-
ing). Control patients were taken from other clinics in 
the hospital. Subjects with known optic neuropathies, eg, 
ischemic and other eye conditions such as retinal detach-
ment that could potentially show retinal asymmetry, were 
excluded from both groups. Patients who were either not 
deemed able to sit comfortably at the equipment or whose 
vision was too poor to maintain ﬁ  xation were excluded. 
All test subjects gave their informed consent to participate 
in the study.
The Pupilmetrix™ PLR60 (Figure 1) carries out a test 
of retinal function. It combines the established and well 
understood PLR with infrared pupilometry (IRP) technology 
to provide data on the response of the pupil to a series of 
specially designed stimuli. Both PLR and IRP are commonly 
used in ophthalmology and optometry. Using specially 
designed software the device calculates a result that indicates 
the presence or absence of asymmetric damage to the nerve 
f ibre layer of the retina.
Examination takes place in a darkened room with minimal 
distractions (noise and light). After a short period of dark 
adjustment, the subject is asked to lean on the chin and head 
rest and look at a red-cross (ﬁ  xation target) that appears on 
the stimulus screen. The non-test eye is covered with an eye 
patch and the pupilometer is focused on the test eye.
Each eye is tested independently by stimulating the retina 
with a controlled and deﬁ  ned sequence of three different 
shapes (stimuli). The shapes are mirror images about a hori-
zontal meridian that also artiﬁ  cially divides the retina into 
an upper and lower half. During the stimulus sequence the 
shape halves vary in brightness relative to each other and their 
background. The shapes alternate in brightness at a frequency 
of 1 per second for 2 seconds per stimulus pair.
Three stimulus pairs constitute a stimulus cycle of 
6 seconds. Three cycles represent one scan. The stimulus 
shape then changes and the regime repeated to complete the 
second scan. The stimulus shape changes to the third one 
and the regime is repeated. Each whole ‘scan’ therefore lasts 
18 seconds and the subject can relax between scans.
The pupilometer comprises a source of near infrared light 
that illuminates the pupil to form a ‘bright pupil’ against a 
dark background of the iris and a video camera that records 
images of the illuminated pupil at a frequency of 60 Hz. 
Eye tracking software superimposes a circle that deﬁ  nes the 
circumference of the illuminated pupil. This is called ‘pupil 
discrimination’ and is the basis of tracking changes in the 
pupil diameter.
As the upper and lower stimuli change in brightness 
relative to their background, the pupil dilates or contracts in 
response. This is the pupillary light reﬂ  ex. The pupilometer 
detects and records these changes.
Results
Patient details
Thirty non-glaucoma patients and 30 glaucoma patients were 
tested. One glaucoma patient was excluded from the study 
because of inability to sit comfortably at the PLR60, discov-
ered after the test was begun. Patients were not age or sex 
matched due to the consecutive nature of the recruitment.
The mean (SD) and range of age of the non-glaucoma 
group was 59.6 (16.7), range 20 to 82 years and 69.9 (13.6), 
for the glaucoma group mean (SD), range 24 to 91 years.
A total of 118 eyes were tested. In all patients a test 
outcome was obtained in at least one eye but could not be 
obtained for 8 eyes (6.8%). In 5 of these cases, this was due 
to the patient blinking ‘excessively’ (greater than 9 times) so 
preventing enough pupil diameter data to enable a contrast Clinical Ophthalmology 2009:3 125
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Figure 1 The Pupilmetrix™ PLR60. a) Device layout; b) Patient positioning; c) The peripheral stimulus pattern.Clinical Ophthalmology 2009:3 126
Wride et al
balance result to be calculated. The remaining 3 losses were 
due to poor data quality preventing the PLR60 software 
from calculating a result. Poor data quality typically arose 
when other stimuli, eg, sudden sounds and distractions 
overwhelmed the intended stimulus resulting in poor corre-
lation between the three stimulus cycles that comprise each 
scan and preventing meaningful calculation of a result. The 
possibility of reducing data loss due to these causes is being 
investigated.
None of the patients tested required correction of their sight 
in order to adequately see the ﬁ  xation target and stimuli.
Sensitivity and speciﬁ  city by patient
Results were analyzed for sensitivity and speciﬁ  city using 
the clinical diagnosis as the reference standard. Since the 
intended use of the PLR60 is for the detection of (screening 
for) glaucoma, sensitivity and speciﬁ  city were estimated 
per patient (rather than per eye) recording retinal damage in 
either eye as a test positive result.
The receiver operator curve (ROC), was calculated using 
the highest absolute value of the six contrast balance values 
for each patient and is shown in Figure 2. Area under the 
curve was 0.907 with a standard error of 0.0408 and 95% 
conﬁ  dence interval (CI) of 0.802 to 0.967.
Using a 2 × 2 diagnostic table, sensitivity and speciﬁ  city 
were calculated to be 93.1% (95% CI 77.2%–99.2%) and 
76.7% (95% CI 57.7%–90.1%).
In both cases, ‘no test outcomes’ were excluded from 
the analysis.
Agreement with clinical diagnosis
The level of agreement between the PLR60 test outcome 
and clinical diagnosis was estimated for each eye tested 
and statistical signiﬁ  cance determined using kappa values. 
Overall agreement between the PLR60 test outcome and 
clinical diagnosis (glaucoma positive or negative) was 84.7% 
(K = 0.6957, 95% CI, 0.5153–0.8761).
Of the 110 eyes with test outcomes, 53 were from 
glaucoma patients and 57 were from control subjects. Of 
the 29 glaucoma patients, 9 had bilateral glaucoma and the 
remainder had glaucoma in one eye only. Agreement between 
the PLR60 test outcome and clinical diagnosis (glaucoma 
positive or negative) per eye for the glaucoma positive group 
was 43/53 (81%). For the control group, agreement between 
the PLR60 test outcome and clinical diagnosis (glaucoma 
negative) per eye was 50/57 (87.7%).
Test time
Test times were calculated from the number of scans taken 
to obtain a result for each eye multiplied by the ﬁ  xed time 
for each scan and so represent the time the PLR60 took to 
scan both eyes not the overall duration of the test. Average 
(SD) test times (min:sec) for both eyes were 3:21 (0:33) 
minutes for the glaucoma group and 2:40 (0:35) minutes for 
the non-glaucoma group. Figure 3 shows the distribution of 
test times. The control group took less time to complete the 
test, with 90% of patients completing the test for both eyes 
in 3.5 minutes and all completing within 4 minutes. For the 
glaucoma group, the ﬁ  gures were 4 minutes and 4.5 minutes 
respectively.
Discussion
A detailed description of the principles of the Pupilmetrix™ 
PLR60 test can be found in Chen.5 In summary, the relative 
pupillomotor sensitivity is determined for corresponding 
superior and inferior retinal territories within the same eye. 
The test also uses stimuli larger than those used in classic 
perimetry to elicit the PLR response. These stimuli shapes 
are named the Paracentral, Bjerrum and Peripheral (out to 
20 degrees) and cover a large portion of the area of the visual 
ﬁ  eld most subject to glaucomatous loss.1 This may be thought 
of as using the same retina as a control and an internal control 
of this sort could potentially reduce test-retest variability.
During the test, the non-test eye is covered to exclude 
light. The patient observes the stimuli on an LCD screen and 
ﬁ  xes their gaze on a small target cross. There is no direct 
interaction between the patient and the device since an in-
built infra-red pupilometer automatically tracks the changes 
in pupil diameter in response to the stimuli. This feature of 
the test provides the objectivity that is sought after in tests 
of visual ﬁ  eld function.
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An effect of the large sizes of the stimuli used in the 
PLR60 test is that correction is not required within ±6 
dipotres of focus on the ﬁ  xation target (HJ Wyatt, personal 
communication). At the distance between the subject’s eye 
and the stimulus screen this means that patients who are 
between +1.5D hyperopic (in the absence of accommoda-
tion) and –10.5D myopic will be satisfactorily focused on 
the stimuli.
The test yields a contrast balance (CBal) value for each 
stimulus shape indicating the relative sensitivity to the upper 
and lower stimuli and thus the level of asymmetric damage 
present in each region of the stimulated retina. The closer 
the magnitude of the Cbal result is to zero the less asym-
metric damage is present. Numerical CBal values for each 
stimulus pair (scan) are categorized as normal, marginal or 
abnormal by comparing the result for each stimulus shape 
to preset limit values. The test outcome summarizes the 
results of each set of scans for each eye and shows either no 
damage is indicated where all three scans are within normal 
limits, damage is suspected where at least one scan shows 
a ‘marginal’ defect, or damage is indicated where at least 
one scan shows an abnormal defect. Damage suspected and 
damage indicated results were treated as ‘test postives’. No 
damage indicated was treated as ‘test negative’.
In their Health Technology Assessment Report of 2007 
for The National Institute for Health Research, Burr et al 
undertook a systematic review of studies that reported the 
diagnostic accuracy of various screening tests for open 
angle glaucoma.7 The sensitivity and speciﬁ  city results for 
the PLR60 compare well with those of other tests of visual 
function and eye examination reported by Burr. For example, 
standard automated suprathreshold perimetry was shown to 
have a sensitivity of 71% and a speciﬁ  city of 85% by deter-
mining summary receiver-operating characteristics for these 
parameters from 9 studies.8 The sensitivity of the PLR60 
test is high at 93.1% compared with other tests studied in 
the assessment. The speciﬁ  city of 76.7% may be considered 
somewhat low for a screening test but again is comparable 
to that of other tests studied. A possible hypothesis could be 
that the PLR60 test is detecting early stage (ie, earlier than 
can be diagnosed clinically) retinal damage associated with 
glaucoma (or possibly other sub-clinical optic neuropathies) 
although this needs to be investigated. In the context of 
optometric screening (usually every 2 years in the UK), the 
speciﬁ  city of the PLR60 is unlikely to be a problem, the high 
sensitivity being important to detect glaucoma as and when 
it occurs. It should also be noted that the absence of age 
matching could potentially artiﬁ  cially increase the diagnostic 
accuracy of the test.
One glaucoma patient, diagnosed with advanced ﬁ  eld losses 
in both eyes, was not detected as having retinal asymmetric 
damage in either eye. The visual ﬁ  eld data showed extensive 
loss in both hemispheres of both eyes, so much so that there was 
no detectable evidence of asymmetric damage to the retina. The 
PLR60 detects differences in the degree of damage to the upper 
and lower retina and where there is no difference will indicate 
no damage detected. Again, in the context of optometric screen-
ing, it is unlikely for a patient to present with such advanced 
damage and if this were to occur, the other tests carried out as 
part of eye examination should detect the disease. Should the 
Pupilmetrix™ test be used in the clinical setting in isolation, 
this limitation would be more important but again would be 
mitigated to a large extent by the results of other tests and 
examinations carried out during diagnosis.
The PLR60 test times, for both glaucoma and control 
patients were in the order of 4 minutes for both eyes. Slightly 
longer test times were seen with glaucoma patients, due to 
the PLR60 repeating scans that indicate an abnormality 
in the retinal response in order to gain a more reliable test 
outcome. These test times are comparable to the 5 minutes 
median times reported by Spry9 for both standard auto-
mated perimetry and frequency doubling technology and 
the 3- to 6-minute test times using Henson screeners reported 
by Tuck and Crick.10 It is recognized that the total time to 
test a patient, which includes preparation and explanation 
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times will be longer than the test times reported here. To be 
consistent with many manufacturers of ﬁ  eld test equipment 
the machine test time and not the overall time is reported. 
Tuck and Crick10 report the explanation and test times for 
various modes of ﬁ  eld screening tests and show them to be 
in the order of a ratio of 1:2, ie, the explanation time is about 
half of the test time.
In this study, the PLR60 showed high levels of agreement 
(over 80%) with the clinical diagnosis of glaucoma both per 
patient and per eye. The incidence of no test outcomes being 
returned for one or other eye (6.8%) is considered to be low 
and suggests the generally good tolerance patients had to 
the test. The objective nature of the PLR60 test, namely that 
the patient does not have to make any decisions about the 
stimulus, is considered to be a signiﬁ  cant factor in achieving 
good patient tolerance and anecdotal feedback from patients 
supported this. It is expected that in regular use such instances 
would be managed and reduced by re-testing the eye after 
resting the patient and/or administering eye drops (eg, artiﬁ  -
cial tears if the patient had dry eyes) if appropriate.
The PLR60 device is a test of visual function and is 
intended for use in Optometric practice as part of the rou-
tine eye examination. The relatively high sensitivity and 
speciﬁ  city and quick test times achieved in this study suggest 
that this is feasible. The performance of current screening 
methods is generally considered poor, with the speciﬁ  city of 
referrals by optometrist being quoted in the range of 40% to 
50%.11,12 With ﬁ  eld testing, patient satisfaction is generally 
low and the time taken has potential economic impacts for 
the optometrists.
Whilst this study involved patients that were likely to 
perform well on the PLR60, it does suggest that the Pupilme-
trix™ PLR60 test has features (objectivity, high sensitivity 
and speciﬁ  city, speed and patient comfort) that can beneﬁ  t 
both the patient and practitioner.
Additional studies with larger numbers and consecutive 
patients will help to more fully elucidate the role of this test 
in everyday practice and determine the test’s sensitivity 
and speciﬁ  city when compared to the clinical diagnosis of 
multiple clinicians.
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